Genetic testing has had a shift in the past ten years, as it has left medical laboratories and entered living rooms.

Myriad Genetics (MYGN) announced MyRisk Hereditary Cancer Test-the gold standard in germline testing-has been expanded to include genes referenced ...

These genes are strongly associated with cancer risk and may have clear clinical actionability, supporting the goal that each addition to the panel provides meaningful insights for patient care. The ...

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced MyRisk®Hereditary Cancer Test —the gold ...

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research studies highlighting advancements in oncology and ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research ...

A new reptile genetics testing company, Phenome, is working on fully mapping out the genomes of a number of reptile species for the first time. The company first made its debut this year at the North ...

Per multiple sources, the integration of genomics into cancer care has transformed treatment approaches, moving away from uniform therapies to precision medicine, where clinical decisions are tailored ...

Kim Kardashian's appearance on The Graham Norton Show has people talking about her California bar exam results. While she was talking to the host of the BBC show, the reality show star expressed how ...

National Testing Agency, NTA will close the registration process for CSIR UGC NET December 2025 exam on October 24, 2025. Candidates who want to apply for Joint CSIR UGC NET exam December 2025 can ...